Study of Ewing and related bone cancers
Part of Cancer clinical trials.
This is an observational study that follows people with Ewing’s sarcoma of the bone and certain “Ewing-like” tumors. It helps doctors understand the extent of disease at diagnosis and track outcomes, which may guide better planning for future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have been diagnosed with Ewing’s sarcoma in the bone
- You (or your child) may also qualify if you have an “Ewing-like” tumor with certain gene changes (EWSR1 fusion, CIC rearrangement, or BCOR rearrangement)
- If your cancer is outside the bone (extraosseous), you may still qualify
- You were diagnosed before age 50
- Your doctors must be able to assess how widespread it is at diagnosis using standard Europe guidelines
- You (or a parent/guardian for a minor) must sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at past patient records to understand what factors affect outcomes and how radiation therapy (high-energy beams to kill cancer cells) helps people with Ewing sarcoma. If you were treated for this bone cancer in the past, your data could help improve treatment for others.
This study looks for special markers called 'biomarkers' in the blood of people with Ewing sarcoma and compares them to people without cancer. It aims to find new ways to understand and potentially monitor this tumor using tiny particles in the blood.
This study looks at the genetic (DNA) features of tumors in children, teens, and young adults with osteosarcoma, Ewing sarcoma, or synovial sarcoma. It may help researchers better understand these cancers by analyzing a fresh tumor sample and a blood sample.
This trial tests a personalized radiation therapy that adjusts the dose based on your tumor. It aims to improve treatment for Ewing sarcoma while limiting side effects.
This trial tests giving radiation therapy before surgery to treat Ewing sarcoma, a bone cancer that's hard to remove completely. The goal is to shrink the tumor first, then remove it surgically, to improve outcomes for patients with high-risk disease.
This study is testing whether a blood test called ProGRP can help doctors see how well treatment is working in people with Ewing sarcoma. If you are newly diagnosed and are about to start your first treatment, this study may help improve how we track your progress.
Hear when a new Ewing Sarcoma of Bone trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.